Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
Background:
Antineoplastons are naturally occurring substances found in urine. Antineoplastons may inhibit the growth of cancer cells. This is a Phase II trial to study the effectiveness of antineoplaston therapy in treating patients with advanced mesothelioma.
Objectives:
 |
Provide treatment with antineoplastons A10 and AS2-1 in patients with stage IV mesothelioma. |
|
Describe the response to, tolerance to, and side effects of this regimen in these patients. |
Location/Contact Information:
Texas
Burzynski Research Institute, Houston, Texas, 77055-6330, United States; Recruiting
Stanislaw R. Burzynski, MD, PhD 713-335-5697
Study chairs or principal investigators
Stanislaw R. Burzynski, MD, PhD, Study Chair
Burzynski Research Institute
